{"disease":{"id":"graves-ophthalmopathy","name":"graves ophthalmopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04704414","title":"Exophthalmometry With 3D Face Scanners","phase":"NA","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05678374","title":"Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT03498417","title":"Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT06693856","title":"Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"Zou Junjie","has_results":false},{"nct_id":"NCT07400757","title":"Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT05126147","title":"Hydroxychloroquine in Mild Graves' Orbitopathy","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07480720","title":"Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Elazıg Fethi Sekin Sehir Hastanesi","has_results":false},{"nct_id":"NCT06275373","title":"The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Walter Reed National Military Medical Center","has_results":false},{"nct_id":"NCT03131726","title":"Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT03324022","title":"Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06413043","title":"Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":78,"lead_sponsor_name":"All India Institute of Medical Sciences, Bhubaneswar","has_results":false},{"nct_id":"NCT03667157","title":"Liver Function After Intravenous Methylprednisolone Administration","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT03938545","title":"ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":65,"lead_sponsor_name":"Immunovant Sciences GmbH","has_results":true},{"nct_id":"NCT04876534","title":"Tocilizumab in Active Moderate-severe Graves' Orbitopathy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":64,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT05793359","title":"Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Medical University of Sofia","has_results":false},{"nct_id":"NCT04927468","title":"Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03066076","title":"Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04598815","title":"Sirolimus for Graves' Orbitopathy (GO)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":54,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT03278964","title":"Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06226545","title":"A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Lassen Therapeutics Inc.","has_results":true},{"nct_id":"NCT04391439","title":"Heart Rhythm After Intravenous Methylprednisolone Administration","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT03122847","title":"Glucocorticoids and Bone in Graves' Ophthalmopathy","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Torben Harsløf","has_results":true},{"nct_id":"NCT03590080","title":"Impact of Intravenous Methylprednisolone Treatment on Blood Pressure","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT06367517","title":"Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT05345119","title":"Sirolimus in Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT05775185","title":"Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Medical University of Sofia","has_results":false},{"nct_id":"NCT03535090","title":"Coagulation After Intravenous Methylprednisolone Administration","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Piotr Miskiewicz","has_results":false},{"nct_id":"NCT03195296","title":"T and B Cells in Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT04488406","title":"Genetics and Epigenetics of Graves' Orbitopathy","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT03922321","title":"Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Immunovant Sciences GmbH","has_results":true},{"nct_id":"NCT03708627","title":"Bimatoprost as a Treatment for Graves' Orbitopathy","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":3,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT01114503","title":"A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}